Tuneable genetic ‘clocks’ might lead to improved biotech strategies
Imperial scientists have worked out how to fine-tune cellular clocks, which might lead to optimised production of drugs, biofuels and other chemicals.
1
E. coli rewired to control growth as experts let them make proteins for medicine
Experts have equipped biotech workhorse bacteria with feedback control mechanism to balance growth with making protein products.
Revealing the hidden biotech potential of unexplored organisms
Imperial researchers have developed a new, “cell-free” approach to investigating previously unexplored bacteria for biotechnology applications.
Group B streptococcus analysis reveals new insights for infection prevention
An analysis of group B streptococcus infections has revealed unexpected transmission events.
Children's drug-resistant bugs could render common antibiotics ineffective
Rising levels of drug-resistance in bacteria that cause childhood infections could render common antibiotics ineffective, a study warns.
International Summit on Serious Health Games
Full day of interactive events concentrating on Serious Health Games modifying prescribing behaviour
Premature births linked to changes in mother's bacteria
Changes to the communities of microbes living in the reproductive tract of pregnant women could help to spot those at risk of giving birth prematurely
Newly-discovered TB blood signal provides early warning for at-risk patients
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study.
Glucose in the airways could increase infections in lung disease patients
People with the lung disease COPD have higher levels of glucose in their airways, researchers have shown for the first time.
1
Increasing vaccine coverage in developing countries focus of new Imperial hub
A 10 million pound Future Vaccine Manufacturing Hub led by Imperial College London has officially launched.
